Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
NCT07628634 · Status: RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2026-07-31
Summary
This is a pilot clinical trial determining the effect of a Methionine-reduced diet on serum levels in subjects with solid tumors. These are subjects who will receive systemic standard of care cancer therapy.
Conditions
- Adenocarcinoma
- Basal Cell Carcinoma
- Squamous Cell Carcinoma
- Transitional Cell Carcinoma
- Ductal Carcinoma
- Osteosarcoma
- Soft Tissue Sarcoma
- Ewing Sarcoma
- Rhabdomyosarcoma
- Leiomyosarcoma
- Melanoma
- Germ Cell Tumor
- Lymphoma
- Endocrine Tumor
- Glioma
Interventions
- OTHER
-
Methionine-Reduced Diet
Normal diet days 1-3 and 8, Methionine-Reduced Diet days 4-7, standard of care cancer treatment initiation on day 8.
Sponsors & Collaborators
-
University of California, Irvine
lead OTHER
Principal Investigators
-
Zhaohui A Arter, MD · Chao Family Comprehensive Cancer Center
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-05-01
- Primary Completion
- 2027-05-01
- Completion
- 2028-05-01
Countries
- United States
Study Locations
More Related Trials
-
SAMe in Prevention of Oxaliplatin-associated Liver Injury
NCT06258525 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases
NCT02859415 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
O6-benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue Sarcoma
NCT00005066 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Patients Undergoing Surgery for Newly Diagnosed High-Grade Osteosarcoma
NCT00645632 ·Status: COMPLETED ·Phase: NA
-
Pilot Study of Metformin in HNSCC to Investigate the Effects of MF, Tumor Genotype and MF-genotype Interactions, on Tumor Metabolism and Anoikis
NCT02402348 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies
NCT07098299 ·Status: RECRUITING ·Phase: PHASE1
-
Evaluate The Toxicity And Feasibility Of Intra-Tumoral Injection
NCT00668382 ·Status: COMPLETED ·Phase: PHASE1
-
Gemcitabine Plus Ascorbate for Sarcoma in Adults
NCT03468075 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma
NCT04162015 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Soy Isoflavone in Combination With Radiation Therapy and Cisplatin in SCC of the Head and Neck
NCT02075112 ·Status: COMPLETED ·Phase: PHASE1
-
Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
NCT00891072 ·Status: COMPLETED ·Phase: PHASE1
-
Randomized Phase 2 Trial of Pre-chemotherapy Leukine vs. Leukine-Dexamethasone in Combination With Gemzar & 5-FU in Patients With Metastatic Renal Cell Carcinoma
NCT00176280 ·Status: WITHDRAWN ·Phase: PHASE2
-
Dichloroacetate (DCA) in Patients With Previously Treated Metastatic Breast or Non-Small Cell Lung Cancer (NSCL)
NCT01029925 ·Status: TERMINATED ·Phase: PHASE2
-
A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors
NCT05572684 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
PNU-93914 in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus
NCT00016900 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 1 Study of PV-10 Chemoablation of Neuroendocrine Tumours (NET) Metastatic to the Liver
NCT02693067 ·Status: UNKNOWN ·Phase: PHASE1
-
Gene Therapy in Treating Patients With Advanced Head and Neck Cancer
NCT00009841 ·Status: COMPLETED ·Phase: PHASE1
-
Localized High-Risk Soft Tissue Sarcomas Of The Extremities And Trunk Wall In Adults: An Integrating Approach Comprising Standard Vs Histotype-Tailored Neoadjuvant Chemotherapy
NCT01710176 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma
NCT00142571 ·Status: COMPLETED ·Phase: PHASE3
-
Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
NCT00103259 ·Status: COMPLETED ·Phase: PHASE2
-
R-(-)-Gossypol Acetic Acid in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer
NCT00773955 ·Status: COMPLETED ·Phase: PHASE2
-
Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery
NCT01553539 ·Status: COMPLETED ·Phase: PHASE2
-
Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
NCT03010150 ·Status: RECRUITING
-
Carboplatin Periocular Injection for Retinoblastoma
NCT02137928 ·Status: UNKNOWN ·Phase: PHASE3
-
A Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated CLL
NCT01750567 ·Status: COMPLETED ·Phase: PHASE2